XML 28 R18.htm IDEA: XBRL DOCUMENT v3.4.0.3
Acquisition (Notes)
3 Months Ended
Mar. 31, 2016
Business Combinations [Abstract]  
Acquisition
Acquisition
On March 18, 2016, the Company acquired Immutopics, Inc., a privately-held, life science research company, based in San Clemente, California. The acquisition has been accounted for in conformity with ASC Topic 805, Business Combinations. Total consideration for the acquisition was $5.5 million, which included $5.1 million in initial cash payments and $0.4 million in fair value of contingent consideration based upon achievement of certain revenue targets through September 2024. The Immutopics portfolio of products will be included with the Company's MicroVue products that serve the bone health research community.